Verve Therapeutics Inc (VERV) Testing Investors’ Patience Right Now
Currently, there are 88.76M common shares owned by the public and among those 66.12M shares have been available to trade. The company’s stock has a 5-day price change of 23.35% and -25.09% over the past three months. VERV shares are trading -26.95% year to date (YTD), with the 12-month market performance down to -48.95% lower. […]
